Lung Cancer News and Research

Latest Lung Cancer News and Research

Subclinical hypothyroidism not a risk factor for heart disease

Persistent subclinical hypothyroidism in older adults is not associated with an increased risk for cardiovascular events, US research shows.

28 Dec 2012

Translating calories to miles prompts significant portion reductions

Food labels that translate the number of calories in a meal into the amount of miles a person would have to walk to burn off those calories may be the most effective for reducing calorie intake, show study findings.

28 Dec 2012

Diabetes interventions show promise in primary care

Two lifestyle-based diabetes interventions developed in a clinical trial could successfully promote weight loss in primary care, research shows.

28 Dec 2012

Reducing fat intake leads to weight loss, smaller waists

Lower-fat diets lead to reduced body weight, body mass index, and waist circumference in adults over the long term even when weight loss is not the intended outcome, according to a meta-analysis published in BMJ.

22 Dec 2012

Bariatric surgery rates dropping in adolescents

Rates of bariatric surgery in adolescents have plateaued since 2003, despite childhood obesity being on the increase, suggest US study findings.

20 Dec 2012

Eating a meal together as a family helps children eat more healthily

Study results suggest that eating as little as one or two meals together as a family per week can significantly improve the amount of fruit and vegetables that children consume on a regular basis.

20 Dec 2012

Adiponectin flags up pancreatic cancer risk

Circulating levels of adiponectin may provide a novel marker for identifying individuals who are at an increased risk for pancreatic cancer, report researchers.

19 Dec 2012

EMD Serono's L-BLP25 Phase III NSCLC trial does not meet primary endpoint

EMD Serono, a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that the Phase III STARTa trial of its investigational product L-BLP25 (formerly referred to as Stimuvax) in patients with unresectable, locally advanced stage IIIA or IIIB non-small cell lung cancer (NSCLC) did not meet its primary endpoint to demonstrate a statistically significant improvement in overall survival (OS).

19 Dec 2012

GTx achieves enrollment goal for pivotal Phase III clinical studies of enobosarm

GTx, Inc. today announced that it has attained its enrollment goal for both of its pivotal Phase III clinical studies of enobosarm to prevent and treat muscle wasting in non-small cell lung cancer patients.

17 Dec 2012

Immunohistochemistry reliable in identifying ALK rearrangement: Study

Favorable results have led to crizotinib gaining approval for the treatment of advanced stage ALK-positive non-small cell lung cancer (NSCLC) in Japan, the United States, Canada, and several other countries in Europe and Asia.

17 Dec 2012

Strong unadjusted relationship between COPD, pneumonia and lung cancer

Chronic obstructive pulmonary disease (COPD) and lung cancer are two of the most important smoking-related diseases worldwide, with a huge combined mortality bur-den. Many consider the presence of COPD itself to be an independent risk factor for lung cancer. Others argue that smoking contributes to both COPD and lung cancer.

17 Dec 2012

American Thoracic Society, IASLC and ERS propose new sub-classification of lung adenocarcinomas

The International Association for the Study of Lung Cancer (IASLC), the American Thoracic Society (ATS), and the European Respiratory Society (ERS), have proposed a new sub-classification of lung adenocarcinomas.

16 Dec 2012

Endocyte picks Medidata Solutions cloud-based platform to support clinical trials

Biopharmaceutical company Endocyte has selected the Medidata Solutions cloud-based platform to support the execution of multiple ongoing clinical trials focused on the development of targeted therapies for cancer and other serious diseases.

15 Dec 2012

FDA grants accelerated approval to ARIAD’s Iclusig for treatment of CML, Ph+ ALL

ARIAD Pharmaceuticals, Inc. today announced that following a priority review, the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Iclusig (ponatinib) for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) that is resistant or intolerant to prior TKI therapy.

14 Dec 2012

Mobiles assist weight-loss interventions

Mobile phone technology can be used to enhance the effect of weight-loss programs, research shows.

14 Dec 2012

Visual impairment and diabetes increase side by side

Visual impairment that is not explained by refractive error is increasing, as is the prevalence of diabetes – particularly diabetes lasting 10 years or longer, show US study results.

14 Dec 2012

Diuretic-based antihypertensive therapy touted for obese

Diuretic-based antihypertensive regimens may be preferable to calcium channel blocker-based therapy in patients who are obese, suggest researchers writing in The Lancet.

13 Dec 2012

Linking food costs to nutritional value may benefit health

Research suggests that the introduction of taxes on less healthy foods, such as sugary drinks and foods high in saturated fat, and subsidies for healthy food, such as fruit and vegetables, could significantly improve peoples’ health.

13 Dec 2012

Opioids already in the body can enhance malignant tendencies of human cancer cells

A study led by University of Chicago researcher Patrick A. Singleton, Ph.D. and published in the journal Anesthesiology has shown that, even without the addition of further opioids such as morphine, opioids already in the body can enhance the malignant tendencies of human cancer cells.

13 Dec 2012

Review describes current state of lung cancer care

A review in the December issue of the journal Archives of Pathology & Laboratory Medicine by Paul Bunn Jr, MD, University of Colorado Cancer Center investigator and past president of ASCO, IASLC and AACI describes the current state of lung cancer care.

12 Dec 2012